Stock price when the opinion was issued
Has been very negative on this name. Thematically they have incurred a ton of debt to develop oil sands and when you are the marginal cost barrel in the oil sands and financing it with debt, it is a risky business and it didn’t work out for them. Have gone through a process of management change, selling assets, etc. Still have a lot of challenges ahead.
7.5% dividend. One of the big laboratories with 30% market share in Ontario. Recently cut dividend and they are selling some of their diagnostic assets, which he thinks are all good things. But 75% of cash flows are from medical labs. CML renegotiates contracts with the Ministry of Health and they are cutting back on healthcare. The contract is being renegotiated this year. Be cautious right now. They are doing the right things so they are coming back to the core side of their original business.